TP53 and cancer: The trans-targets were mainly enriched in the TNF signaling pathway, pathways in cancer, p53 signaling pathway, MAPK signaling pathway, NF-kappa B signaling pathway, C-type lectin receptor signaling pathway, and apoptosis (Fig. 4F, Supplemental Table S6).